Performance of a Commercial, Type-Specific Enzyme-Linked Immunosorbent Assay for Detection of Herpes Simplex Virus Type 2-Specific Antibodies in Ugandans

  • Oliver Laeyendecker
  • , Charla Henson
  • , Ronald H. Gray
  • , Ruby H.N. Nguyen
  • , Bobbi Jo Horne
  • , Maria J. Wawer
  • , David Serwadda
  • , Noah Kiwanuka
  • , Rhoda Ashley Morrow
  • , Wayne Hogrefe
  • , Thomas C. Quinn

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Two hundred forty-eight human immunodeficiency virus (HIV)-positive and 496 HIV-negative subjects in Uganda were tested by HerpeSelect herpes simplex virus type 2 enzyme-linked immunosorbent assay (ELISA) and Western blotting to optimize the ELISA for use in this population. A higher index cutoff value was required for optimal sensitivity and specificity, and overall performance of the assay was not affected by HIV status.

Original languageEnglish (US)
Pages (from-to)1794-1796
Number of pages3
JournalJournal of clinical microbiology
Volume42
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Dive into the research topics of 'Performance of a Commercial, Type-Specific Enzyme-Linked Immunosorbent Assay for Detection of Herpes Simplex Virus Type 2-Specific Antibodies in Ugandans'. Together they form a unique fingerprint.

Cite this